We are pleased to announce that as of October 1, 2018, Aetna — a Fortune 500 Company that has been described by the New York Times as “one of the most progressive actors
in corporate America” — has accepted Acutis as a national, in-network provider.  


Acutis maintains its commitment to its clients and the industry with:

  1. A no-compromise work ethic that adheres to protocols that have no tolerance for error. 

  2. Our proprietary 728 Patient Report™ that enables clinical decisions by pointing out abuse
    of prescription/illicit drugs that are too often missed by providers.

  3. A sense of urgency — 97% of our reports are delivered by the next business day.

  4. A payor-centric approach that believes good healthcare delivered
    at the lowest cost is a business imperative. 

  5. An adherence to “medical necessity” as the only basis for testing,
    which leads to better patient outcomes with minimal testing.

Only a few, select clinical toxicology laboratories have been accepted as Aetna in-network providers. We see our acceptance as an affirmation, not only for Acutis as a whole, but of every single member of our company, from our PhDs to our support staff. We are honored to have earned Aetna’s trust and will work hard and smart to keep it.

“We will continue to refine our science and technology to ensure greater accuracy and consistency, as well as regular cost savings and rapid turn-around time.
What’s more, our ongoing investment in research and development will lead to greater advancements in clinical toxicology, as well as state-of-the-art diagnostic tests in infectious disease and molecular diagnostics.”
— Jibreel Sarij, Acutis’ CEO

Click, act & go



Sign in to view your patients' results and order new tests. 


Make a payment

 I am paying on behalf of a patient or a practice.


Arrange a sample pick-up

Our internal systems ensure accurate
and timely pick-up of samples. 

Order supplies

 Our logistics specialists see that materials are
shipped exactly where and when you need them.   


Our specialties


A corporate culture that
will not compromise or tolerate error.


Tests and systems that detect prescription drug abuse and misuse. 

& addiction detection

Innovative practices and procedures that quickly deliver critical information. 


Acutis Autumn Symposium

You are invited to a special event! Tuesday, October 23, 2018 (6-9 pm), dinner at Longfellows featuring Dr. Jeffrey Fudin, PharmD. Clinical pharmacy specialist, opioid risk management. Read more…

News & insights

Acutis steps up at the 19th Annual ASAP Conference: From September 23rd through the 27th 2018,  CEO Jibreel Sarij and Sales Specialists Jared Blais and Emily Talarico attended the Alcoholism and Substance Abuse Providers of New York State (ASAP) Annual Conference in Syracuse, New York. 
Read more…